COVID-19 Impact on Global Immuno Oncology Assays Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: C7AC4EF750C1EN
QYResearch

Abstracts

This report focuses on the global Immuno Oncology Assays status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immuno Oncology Assays development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Thermo Fischer Scientific
• Roche Diagnostics
• Agilent Technologies
• Illumina

Market segment by Type, the product can be split into

• Immunoassay
• Flow Cytometry
• PCR
• Next Generation Sequencing

Market segment by Application, split into

• Research
• Clinical Diagnostics

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Immuno Oncology Assays status, future forecast, growth opportunity, key market and key players.
• To present the Immuno Oncology Assays development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Immuno Oncology Assays are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immuno Oncology Assays Revenue
1.4 Market Analysis by Type
  1.4.1 Global Immuno Oncology Assays Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Immunoassay
  1.4.3 Flow Cytometry
  1.4.4 PCR
  1.4.5 Next Generation Sequencing
1.5 Market by Application
  1.5.1 Global Immuno Oncology Assays Market Share by Application: 2020 VS 2026
  1.5.2 Research
  1.5.3 Clinical Diagnostics
1.6 Coronavirus Disease 2019 (Covid-19): Immuno Oncology Assays Industry Impact
  1.6.1 How the Covid-19 is Affecting the Immuno Oncology Assays Industry
    1.6.1.1 Immuno Oncology Assays Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Immuno Oncology Assays Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Immuno Oncology Assays Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Immuno Oncology Assays Market Perspective (2015-2026)
2.2 Immuno Oncology Assays Growth Trends by Regions
  2.2.1 Immuno Oncology Assays Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Immuno Oncology Assays Historic Market Share by Regions (2015-2020)
  2.2.3 Immuno Oncology Assays Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Immuno Oncology Assays Market Growth Strategy
  2.3.6 Primary Interviews with Key Immuno Oncology Assays Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Immuno Oncology Assays Players by Market Size
  3.1.1 Global Top Immuno Oncology Assays Players by Revenue (2015-2020)
  3.1.2 Global Immuno Oncology Assays Revenue Market Share by Players (2015-2020)
  3.1.3 Global Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immuno Oncology Assays Market Concentration Ratio
  3.2.1 Global Immuno Oncology Assays Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Immuno Oncology Assays Revenue in 2019
3.3 Immuno Oncology Assays Key Players Head office and Area Served
3.4 Key Players Immuno Oncology Assays Product Solution and Service
3.5 Date of Enter into Immuno Oncology Assays Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Immuno Oncology Assays Historic Market Size by Type (2015-2020)
4.2 Global Immuno Oncology Assays Forecasted Market Size by Type (2021-2026)

5 IMMUNO ONCOLOGY ASSAYS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Immuno Oncology Assays Market Size by Application (2015-2020)
5.2 Global Immuno Oncology Assays Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Immuno Oncology Assays Market Size (2015-2020)
6.2 Immuno Oncology Assays Key Players in North America (2019-2020)
6.3 North America Immuno Oncology Assays Market Size by Type (2015-2020)
6.4 North America Immuno Oncology Assays Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Immuno Oncology Assays Market Size (2015-2020)
7.2 Immuno Oncology Assays Key Players in Europe (2019-2020)
7.3 Europe Immuno Oncology Assays Market Size by Type (2015-2020)
7.4 Europe Immuno Oncology Assays Market Size by Application (2015-2020)

8 CHINA

8.1 China Immuno Oncology Assays Market Size (2015-2020)
8.2 Immuno Oncology Assays Key Players in China (2019-2020)
8.3 China Immuno Oncology Assays Market Size by Type (2015-2020)
8.4 China Immuno Oncology Assays Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Immuno Oncology Assays Market Size (2015-2020)
9.2 Immuno Oncology Assays Key Players in Japan (2019-2020)
9.3 Japan Immuno Oncology Assays Market Size by Type (2015-2020)
9.4 Japan Immuno Oncology Assays Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Immuno Oncology Assays Market Size (2015-2020)
10.2 Immuno Oncology Assays Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immuno Oncology Assays Market Size by Type (2015-2020)
10.4 Southeast Asia Immuno Oncology Assays Market Size by Application (2015-2020)

11 INDIA

11.1 India Immuno Oncology Assays Market Size (2015-2020)
11.2 Immuno Oncology Assays Key Players in India (2019-2020)
11.3 India Immuno Oncology Assays Market Size by Type (2015-2020)
11.4 India Immuno Oncology Assays Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Immuno Oncology Assays Market Size (2015-2020)
12.2 Immuno Oncology Assays Key Players in Central & South America (2019-2020)
12.3 Central & South America Immuno Oncology Assays Market Size by Type (2015-2020)
12.4 Central & South America Immuno Oncology Assays Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Thermo Fischer Scientific
  13.1.1 Thermo Fischer Scientific Company Details
  13.1.2 Thermo Fischer Scientific Business Overview and Its Total Revenue
  13.1.3 Thermo Fischer Scientific Immuno Oncology Assays Introduction
  13.1.4 Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2015-2020))
  13.1.5 Thermo Fischer Scientific Recent Development
13.2 Roche Diagnostics
  13.2.1 Roche Diagnostics Company Details
  13.2.2 Roche Diagnostics Business Overview and Its Total Revenue
  13.2.3 Roche Diagnostics Immuno Oncology Assays Introduction
  13.2.4 Roche Diagnostics Revenue in Immuno Oncology Assays Business (2015-2020)
  13.2.5 Roche Diagnostics Recent Development
13.3 Agilent Technologies
  13.3.1 Agilent Technologies Company Details
  13.3.2 Agilent Technologies Business Overview and Its Total Revenue
  13.3.3 Agilent Technologies Immuno Oncology Assays Introduction
  13.3.4 Agilent Technologies Revenue in Immuno Oncology Assays Business (2015-2020)
  13.3.5 Agilent Technologies Recent Development
13.4 Illumina
  13.4.1 Illumina Company Details
  13.4.2 Illumina Business Overview and Its Total Revenue
  13.4.3 Illumina Immuno Oncology Assays Introduction
  13.4.4 Illumina Revenue in Immuno Oncology Assays Business (2015-2020)
  13.4.5 Illumina Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Immuno Oncology Assays Key Market Segments
Table 2. Key Players Covered: Ranking by Immuno Oncology Assays Revenue
Table 3. Ranking of Global Top Immuno Oncology Assays Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immuno Oncology Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunoassay
Table 6. Key Players of Flow Cytometry
Table 7. Key Players of PCR
Table 8. Key Players of Next Generation Sequencing
Table 9. COVID-19 Impact Global Market: (Four Immuno Oncology Assays Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Immuno Oncology Assays Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Immuno Oncology Assays Players to Combat Covid-19 Impact
Table 14. Global Immuno Oncology Assays Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Immuno Oncology Assays Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Immuno Oncology Assays Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Immuno Oncology Assays Market Share by Regions (2015-2020)
Table 18. Global Immuno Oncology Assays Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Immuno Oncology Assays Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Immuno Oncology Assays Market Growth Strategy
Table 24. Main Points Interviewed from Key Immuno Oncology Assays Players
Table 25. Global Immuno Oncology Assays Revenue by Players (2015-2020) (Million US$)
Table 26. Global Immuno Oncology Assays Market Share by Players (2015-2020)
Table 27. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno Oncology Assays as of 2019)
Table 28. Global Immuno Oncology Assays by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Immuno Oncology Assays Product Solution and Service
Table 31. Date of Enter into Immuno Oncology Assays Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 34. Global Immuno Oncology Assays Market Size Share by Type (2015-2020)
Table 35. Global Immuno Oncology Assays Revenue Market Share by Type (2021-2026)
Table 36. Global Immuno Oncology Assays Market Size Share by Application (2015-2020)
Table 37. Global Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 38. Global Immuno Oncology Assays Market Size Share by Application (2021-2026)
Table 39. North America Key Players Immuno Oncology Assays Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Immuno Oncology Assays Market Share (2019-2020)
Table 41. North America Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 42. North America Immuno Oncology Assays Market Share by Type (2015-2020)
Table 43. North America Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 44. North America Immuno Oncology Assays Market Share by Application (2015-2020)
Table 45. Europe Key Players Immuno Oncology Assays Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Immuno Oncology Assays Market Share (2019-2020)
Table 47. Europe Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Immuno Oncology Assays Market Share by Type (2015-2020)
Table 49. Europe Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Immuno Oncology Assays Market Share by Application (2015-2020)
Table 51. China Key Players Immuno Oncology Assays Revenue (2019-2020) (Million US$)
Table 52. China Key Players Immuno Oncology Assays Market Share (2019-2020)
Table 53. China Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 54. China Immuno Oncology Assays Market Share by Type (2015-2020)
Table 55. China Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 56. China Immuno Oncology Assays Market Share by Application (2015-2020)
Table 57. Japan Key Players Immuno Oncology Assays Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Immuno Oncology Assays Market Share (2019-2020)
Table 59. Japan Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Immuno Oncology Assays Market Share by Type (2015-2020)
Table 61. Japan Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Immuno Oncology Assays Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Immuno Oncology Assays Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Immuno Oncology Assays Market Share (2019-2020)
Table 65. Southeast Asia Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Immuno Oncology Assays Market Share by Type (2015-2020)
Table 67. Southeast Asia Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Immuno Oncology Assays Market Share by Application (2015-2020)
Table 69. India Key Players Immuno Oncology Assays Revenue (2019-2020) (Million US$)
Table 70. India Key Players Immuno Oncology Assays Market Share (2019-2020)
Table 71. India Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 72. India Immuno Oncology Assays Market Share by Type (2015-2020)
Table 73. India Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 74. India Immuno Oncology Assays Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Immuno Oncology Assays Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Immuno Oncology Assays Market Share (2019-2020)
Table 77. Central & South America Immuno Oncology Assays Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Immuno Oncology Assays Market Share by Type (2015-2020)
Table 79. Central & South America Immuno Oncology Assays Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Immuno Oncology Assays Market Share by Application (2015-2020)
Table 81. Thermo Fischer Scientific Company Details
Table 82. Thermo Fischer Scientific Business Overview
Table 83. Thermo Fischer Scientific Product
Table 84. Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2015-2020) (Million US$)
Table 85. Thermo Fischer Scientific Recent Development
Table 86. Roche Diagnostics Company Details
Table 87. Roche Diagnostics Business Overview
Table 88. Roche Diagnostics Product
Table 89. Roche Diagnostics Revenue in Immuno Oncology Assays Business (2015-2020) (Million US$)
Table 90. Roche Diagnostics Recent Development
Table 91. Agilent Technologies Company Details
Table 92. Agilent Technologies Business Overview
Table 93. Agilent Technologies Product
Table 94. Agilent Technologies Revenue in Immuno Oncology Assays Business (2015-2020) (Million US$)
Table 95. Agilent Technologies Recent Development
Table 96. Illumina Company Details
Table 97. Illumina Business Overview
Table 98. Illumina Product
Table 99. Illumina Revenue in Immuno Oncology Assays Business (2015-2020) (Million US$)
Table 100. Illumina Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Immuno Oncology Assays Market Share by Type: 2020 VS 2026
Figure 2. Immunoassay Features
Figure 3. Flow Cytometry Features
Figure 4. PCR Features
Figure 5. Next Generation Sequencing Features
Figure 6. Global Immuno Oncology Assays Market Share by Application: 2020 VS 2026
Figure 7. Research Case Studies
Figure 8. Clinical Diagnostics Case Studies
Figure 9. Immuno Oncology Assays Report Years Considered
Figure 10. Global Immuno Oncology Assays Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Immuno Oncology Assays Market Share by Regions: 2020 VS 2026
Figure 12. Global Immuno Oncology Assays Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Immuno Oncology Assays Market Share by Players in 2019
Figure 15. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno Oncology Assays as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Immuno Oncology Assays Revenue in 2019
Figure 17. North America Immuno Oncology Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Immuno Oncology Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Immuno Oncology Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Immuno Oncology Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Immuno Oncology Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Immuno Oncology Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Immuno Oncology Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Thermo Fischer Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Thermo Fischer Scientific Revenue Growth Rate in Immuno Oncology Assays Business (2015-2020)
Figure 26. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche Diagnostics Revenue Growth Rate in Immuno Oncology Assays Business (2015-2020)
Figure 28. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Agilent Technologies Revenue Growth Rate in Immuno Oncology Assays Business (2015-2020)
Figure 30. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Illumina Revenue Growth Rate in Immuno Oncology Assays Business (2015-2020)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed